References
- Welsch C. W., Nagasawa H. Prolactin and murine mammary tumorigenesis: A review. Cancer, Res 1977; 37: 951
- Nagasawa H. Prolactin and human breast cancer. A review. Eur. J. Cancer 1979; 15: 267–79
- Sitruk-Ware R., Sterkers N., Mowszowicz I., Mauvais-Jarvis P. Inadequate corpus luteal function in women with benign breast disease. J. Clin. Endocrinol. Metab. 1977; 44: 771–4
- Sitruk-Ware R., Sterkers N., Mauvais-Jarvis P. Benign breast disease. I. Hormonal investigation. Obstet. Gynecol. 1979; 53: 457–60
- Brown R. W., Meehan C., Martin F. I. R., Bhathal P. S. Breast tumors in patients with hyperprolactinemia. Cancer 1982; 50: 125–9
- Peters F., Pickardt C. R., Zimmermann G., Breckwoldt M. PRL, TSH, and thyroid hormones in benign breast diseases. Klin. Wochenschr. 1981; 59: 403–7
- Martin-Comin J., Pujol-Aniat P., Cararach V., Llavi E., Robyn C. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-Alpha-Ergocryptine (CB-154). Obstet. Gynecol. 1976; 48: 7056
- Mansel R. E., Preece P. E., Hugues L. E. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease. Br.J. Surg. 1978; 65: 724–7
- Mauvais-Jarvis P., Sitruk-Ware R., Kuttenn F. Benign breast disease. Breast Cancer, Advances in Research and Treatment, W. L. McGuire. Plenum Press, New York 1981; Vol. 4: 51–94
- Kuttenn F., Fournier S., Durand J. C., Mauvais-Jarvis P., Baudot N., Doukani A. Estradiol and progesterone receptors in human breast fibroadenomas. J. Clin. Endocrinol. Metab. 1981; 52: 1225–9
- Labrie F., Ferland L., Di Paolo T., Veilleux R. Modulation of prolactin secretion by sex steroids and thyroid hormones. Central and Peripheral Regulation of Prolactin Function, R. M. MacLeod, U. Scapagnini. Raven Press, New York 1980; 97–113
- Sinha Y. N., Selby F. W., Lewis U. J., Vanderlaan W. P. A homologous radio immunoassay for human prolactin. J. Clin. Endocrinol. Metab. 1973; 36: 509–16
- Kumar S., Mansel R. E., Hugues L. E., Edwards C. A., Scanlon M. F. Prediction in pronounced cyclical mastalgia using dynamic tests of prolactin release. Clin. Endocrinol. 1985; 23: 699–704
- Bassler R. Morphology of hormone induced structural changes in the female breast. Curr. Top. Pathol. 1970; 53: 1–90
- Vignon F., Rochefort H. Regulation of estrogen receptors in ovarian-dependent rat mammary tumors. I. Effects of castration and prolactin. Endocrinology 1976; 98: 722–9
- Asboe-Hansen G. Hormonal effects on connective tissue. Physiol. Rev. 1958; 38: 446–62
- Houdebine L. M., Teyssot B., Devinoy E., Ollivier-Bouquet M., Djiane J., Kelly P. A., Delouis C., Kann G., Fevre J. Role of progesterone in the development and the activity of the mammary gland. Progesterone and Progestins, C. W. Bardin, E. Milgrom, P. Mauvais-Jarvis. Raven Press, New York 1983; 297–319
- Crowley W. F., Filicori M., Spratt D. I., Santoro N. F. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Rec. Prog. Horm. Res. 1985; 41: 473–531